Randox showcases future-proofing diagnostic technology at MEDICA 2017 -- MEDICA - World Forum for Medicine


Randox Laboratories Ltd.

Randox showcases future-proofing diagnostic technology at MEDICA 2017

  • World’s first fully automated random-access biochip testing platform to be demonstrated at MEDICA 2017
  • RX modena promising a laboratory revolution will be showcased at Hall 3 stand A08
  • Latest weapon in fight against CVD, diabetes and cancers – Adiponectin – will be featured
  • MEDICA 2017 attendees will be among first in the world to review Acusera 24.7 Live Online version 2.0
Randox Laboratories, the world-leading medical diagnostics manufacturer, is showcasing advancements in laboratory technology at the 2017 MEDICA – World Conference for Medicine conference, being held November 13-16 in Dusseldorf, Germany.

Unveiling its state-of-the-art interactive exhibition stand in Hall 3 stand A08, Randox will host a series of demonstrations of its innovative analysers including the Evidence Evolution and Rx modena, and a number of exciting advances in laboratory medicine, involving  increasing the test menu available to clinicians and improving the connectivity of laboratories across the world to enhance overall quality.

“Through our advancements in laboratory innovation, we’re driving an industry-wide evolution” said Randox CEO, Dr Peter FitzGerald. “Our products are leading the way in innovation and enabling laboratories to transform the way they operate. We will be hosting demonstrations of a wide range of our fully-automated analysers, which are packed with cutting-edge technology and intuitive software. The goal is to provide future-proof diagnostic technology that will create the most efficient and effective laboratories.”

Paving the way is Randox’s patented Biochip Array Technology (BAT). This multi-analyte testing platform is the product of a £250 million research and development project. The ceramic tile measuring 9x9 mm can currently run up to 49 assays simultaneously,100 assays in the near future.   This innovation allows the simultaneous quantitative or qualitative detection from a wide range of analytes from a single sample. It is suitable for use in a wide range of laboratories including clinical, research, hospital, veterinary and forensic and clinical toxicology.

To enhance the benefits of BAT, Randox introduced the Evidence Evolution to its stable of immunoassay analyser platforms. The Evidence Evolution is the world’s first fully automated random-access biochip testing platform, capable of delivering 2640 results in one hour, with the first delivered in just 37 minutes.

Joining the Evolution in Hall 3 stand A08 is the RX modena. This highly reliable, precise, fully automated clinical chemistry analyser can run 1200 tests per hour including ISE. When combined with its unrivalled RX series test menu, it offers a winning combination for all large, multi-disciplinary laboratories.

“We develop more new tests than any other diagnostics manufacturer, and one of the products that we’re showcasing at this year’s MEDICA is Adiponectin,” added Susan Hammond, Global Sales Manager at Randox. “This novel biomarker is a powerful new weapon in the fight against some of the biggest health issues faced throughout the world including diabetes, cancers and cardiovascular disease. As it’s World Diabetes Day on Tuesday 14th November, it’s a great opportunity to draw attention to this array which labs can run as part of their routine testing panel.”

MEDICA attendees will also be among the first to experience the advancements delivered by the latest update for Randox’s Acusera 24.7. This online interlaboratory data management and peer reporting package is now smarter, faster and more powerful than ever before.

Acusera 24.7 is designed to help laboratories efficiently review QC data from all their lab instruments on one central platform, thereby allowing quick and easy identification of QC failures and emerging trends. Unique access to peer group data updated instantly in real-time from our global network of laboratory participants will speed up troubleshooting and help pinpoint the root cause of any QC failures by easily identifying if an issue is isolated or widespread.

The Randox team will be on hand throughout MEDICA 2017 in Hall 3 stand A08. To make an appointment in advance, contact them through the Randox MEDICA webpage.

Visit  www.http://medica-tradefair.randox.com/ for more information. 

For live updates from MEDICA 2017, follow

  • @RandoxQC 
  • @RandoxReagents 
  • @Randox_RXseries
  • @Randoxbio
About Randox Biosciences

Randox Biosciences, part of Randox Laboratories, is dedicated to improving health worldwide through scientific discovery, drug development and diagnostics. Spanning four key divisions; Life Sciences, Pharma Sciences, Research and Molecular; Randox Biosciences offers complete tailored solutions for clinical and research use. From initial cultivation of raw materials for assay development, through to providing companion diagnostics, custom and molecular based assays across a range of therapy areas; Randox Biosciences is a trusted partner supplying quality diagnostic solutions to the clinical, life science, pharmaceutical, research and biopharma industries.

About Randox RX

Patient care is the primary focus of clinical chemistry testing and Randox has developed the RX series of clinical chemistry analysers for high quality semi-automated and fully automated testing. The RX series continues to revolutionise a variety of laboratory types including: Clinical Laboratories, Hospital Laboratories, University & Educational Institutes, Research Laboratories, Veterinary Laboratories and Food & Wine Laboratories. Renowned for quality and reliability, the RX series has one of the most extensive dedicated clinical chemistry test menus on the market guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform. This extensive dedicated test menu of high quality reagents guarantees excellence in patient care ensuring unrivalled precision and accuracy reducing costly test re-runs or misdiagnosis and offering complete confidence in results.

About Randox Reagents

Randox offers an extensive range of diagnostic reagents, giving biochemistry laboratories the opportunity to advance their routine and niche testing. Randox has been providing laboratories with revolutionary diagnostic solutions for over 30 years. Our experience and expertise has facilitated the creation of a leading product portfolio of diagnostic reagents which are internationally recognised as being of the highest quality, offering reliable and rapid diagnosis. Randox offer more than 100 clinical assays, covering testing panels such as antioxidants, basic and comprehensive metabolic profiles, cardiac, coagulation, diabetes, drugs of abuse testing, hepatic function, lipids, renal function, specific proteins, therapeutic drug monitoring and veterinary.

About Randox QC

Quality Control is one of our passions; we believe in producing high quality material that can help streamline procedures, whilst saving time and money for laboratories of all sizes and budgets. With an extensive product offering comprising third party quality controls & calibrators, interlaboratory data management, external quality assessment, and calibration verification, you can count on Randox to deliver trustworthy results time and time again. Just ask one of our 60,000 users worldwide.



Exhibitor Data Sheet